Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue.
Paramyxoviruses, a family of RNA enveloped viruses that includes human parainfluenza virus type 3 (HPIV3), cause the majority of childhood croup, bronchiolitis, and pneumonia worldwide. Infection starts with host cell receptor binding and fusion of the viral envelope with the cell membrane at the cell surface. The fusion process requires interaction of the two viral surface glycoproteins, the hemagglutinin-neuraminidase (HN) and the fusion protein (F). We have previously shown that viruses with an HN/F pair that is highly fusogenic in monolayers of immortalized cells due to mutations in HN's secondary sialic acid binding site are growth impaired in differentiated human airway epithelium (HAE) cultures and in vivo. Here we have shown that adaptation of HPIV3 to growth in the lung is determined by specific features of HN and F that are different from those required for growth in cultured immortalized cells. An HPIV3 virus bearing a mutated HN (H552Q), which is fit and fusogenic in immortalized cells but unfit for growth in the lung, evolved into a less-fusogenic but viable virus in differentiated human airway epithelium. Stepwise evolution led to a progressive decrease in efficiency of fusion activation by the HN/F pair, with a mutation in F first decreasing the activation of F by HN and a mutation in HN's secondary sialic acid binding site decreasing fusion activation further and producing a stable virus. Adaptation of HPIV3 to successful growth in HAE is determined by specific features of HN and F that lead to a less easily activated fusion mechanism.


OBJECTIVE
Human parainfluenza viruses (HPIVs) are paramyxoviruses that cause the majority of childhood cases of croup, bronchiolitis, and pneumonia worldwide, but there are currently no vaccines or antivirals available for treatment. Enveloped viruses must fuse their membrane with the target cell membrane in order to initiate infection. Parainfluenza virus fusion proceeds via a multistep reaction orchestrated by the two glycoproteins that make up its fusion machine. The receptor-binding hemagglutinin-neuraminidase (HN), upon receptor engagement, activates the fusion protein (F) to penetrate the target cell and mediate viral entry. In this study, we show that the precise balance of fusion activation properties of these two glycoproteins during entry is key for infection. In clinically relevant tissues, viruses evolve to acquire a set of fusion features that provide key clues about requirements for infection in human beings.
Departments of Pediatrics and Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, USA.
Samantha G
SG
Palmer
Matteo
M
Porotto
Laura M
LM
Palermo
Luis F
LF
Cunha
Olga
O
Greengard
Anne
A
Moscona
D000220:Adaptation, Biological; D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D004847:Epithelial Cells / Q000821:virology*; D019143:Evolution, Molecular; D015707:HN Protein / Q000235:genetics*; D006801:Humans; D008958:Models, Molecular; D050505:Mutant Proteins / Q000235:genetics; D020125:Mutation, Missense; D010224:Parainfluenza Virus 3, Human / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity / Q000502:physiology*; D011487:Protein Conformation; D014760:Viral Fusion Proteins / Q000235:genetics*; D053586:Virus Internalization
D015707:HN Protein; D050505:Mutant Proteins; D014760:Viral Fusion Proteins; C072983:F protein, parainfluenza virus 3